Katrina Woodin Copeland

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katrina Woodin Copeland. Retrieved from https://idiyas.com/inventor/katrina-woodin-copeland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 10.6

ph-index = 2

Forward Citations = 45(Granted Patents)

Location History:

San Gabriel, CA (US) (2012)
Sudbury, MA (US) (2015 - 2019)

Company Filing History:

5 out of 2,077

Amgen Inc.

patents

Years Active: 2012-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10344041 - Polymorphic forms and co-crystals of a c-Met inhibitor (2019-07-09),

2. 9981988 - Polymorphic forms and co-crystals of a c-Met inhibitor (2018-05-29),

3. 9346798 - Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors (2016-05-24),

4. 9012443 - Bicyclic aryl and heteroaryl sodium channel inhibitors (2015-04-21),

5. 8198448 - Fused heterocyclic derivatives and methods of use (2012-06-12),

Title: Katrina Woodin Copeland: Pioneering Inventor in the Fight Against Cancer

Introduction:

Katrina Woodin Copeland, a visionary inventor hailing from Sudbury, MA (US), is making groundbreaking strides in the field of cancer treatment with her innovative patents. With her remarkable achievements, Katrina is setting new standards in the landscape of technology and healthcare.

Latest Patents:

Katrina Woodin Copeland has amassed an impressive portfolio of inventions, with her latest patents focusing on polymorphic forms and co-crystals of a c-Met inhibitor. These compounds play a crucial role in the treatment, prevention, and amelioration of cancer, showcasing her dedication to advancing medical science.

Career Highlights:

Katrina is a valued member of Amgen Inc., a renowned biotechnology company at the forefront of developing cutting-edge therapies. Through her relentless pursuit of excellence, she has earned recognition for her contributions to the field of oncology and pharmaceuticals.

Collaborations:

In her journey of innovation, Katrina has collaborated closely with esteemed peers such as David Bauer and Alessandro Boezio. Together, they have synergized their expertise to push the boundaries of scientific discovery and bring novel solutions to the forefront of cancer research.

Conclusion:

In conclusion, Katrina Woodin Copeland stands as a beacon of inspiration in the world of inventions, with her groundbreaking work reshaping the landscape of cancer treatment. Her relentless commitment to innovation and her pioneering spirit are paving the way for a brighter, healthier future for generations to come.

Profile summary based on public USPTO records.